Publication date: Sep 08, 2026
To characterize the burden of and identify risk factors for post-coronavirus disease (COVID) condition among high-risk, nonhospitalized patients in Honduras, patients with acute coronavirus disease 2019 (COVID-19) who were discharged from five urban triage facilities were prospectively recruited. These patients were recruited between May and September 2022. Inclusion criteria included a positive COVID-19 antigen test result and either age greater than 60 years or age greater than 45 years with elevated risk for severe COVID-19. Follow-up was conducted at 3 and 4. 5 months by telephone. Multivariable logistic regression was used to identify predictors of post-COVID condition. At enrollment, 98% of participants had received two or more doses of the COVID vaccine. Three months after enrollment, 464/1,133 participants (41%) reported ongoing symptoms. Female sex (adjusted odd ratio [aOR]: 1. 68, 95% CI: 1. 29-2. 19), three or more comorbidities (aOR: 1. 62, 95% CI: 1. 03-2. 55), and the number of symptoms at enrollment (aOR: 2. 41, 95% CI: 1. 59-3. 71 for 7-9 symptoms; aOR 3. 61, 95% CI: 2. 25-5. 86 for 10 or more symptoms) were predictive of ongoing symptoms. A total of 4. 5 months after enrollment, 258/852 patients (30%) reported ongoing symptoms. Female sex (aOR: 1. 82, 95% CI: 1. 31-2. 54), the number of comorbidities (aOR: 1. 87, 95% CI: 1. 07-3. 36 for two comorbidities; aOR: 2. 38, 95% CI: 1. 33-4. 39 for three or more comorbidities), the number of enrollment symptoms (aOR: 1. 73, 95% CI: 1. 05-2. 95 for 7-9 symptoms; aOR: 2. 59, 95% CI: 1. 45-4. 71 for 10 or more symptoms), and three versus four vaccine doses (aOR: 1. 54, 95% CI: 1. 06-2. 22) were predictive of ongoing symptoms. These findings raise concern for an under-recognized burden of post-COVID condition in Honduras. Further research is needed to determine if findings from this high-risk cohort are indicative of post-COVID condition burden among other populations in the region.
| Concepts | Keywords |
|---|---|
| Aor | |
| Burden | |
| Ci | |
| Comorbidities | |
| Condition | |
| Coronavirus | |
| Covid | |
| Enrollment | |
| Honduras | |
| Months | |
| Nonhospitalized | |
| Ongoing | |
| Post | |
| Risk | |
| Symptoms |
Semantics
| Type | Source | Name |
|---|---|---|
| pathway | KEGG | Coronavirus disease |
| disease | MESH | coronavirus disease 2019 |
| disease | MESH | included |
| disease | MESH | post-COVID condition |